HOME : Support : Dialog Search Aids : Bluesheets
Twitter   Facebook   e-Newsletters   Podcsts   RSS Feeds   Share
View Bluesheets by | Database Name | File Number | Subject | OneSearch Categories | Search Options |
172
EMBASE® Alert

Last Loaded on Web: Wednesday, February 01, 2012

Last Update To Bluesheet: April 14, 2009

Bluesheet Contents     PDF version

File Description Dialog File Data DIALINDEX/OneSearch Categories Basic Index Rank
Subject Coverage Document Types Indexed Contact Additional Indexes Predefined Format Options
Tips Geographic Coverage Terms and Conditions Limit Rates
Print Counterparts Special Features Sample Record Sort


File Description [top]

EMBASE AlertTM is a current awareness pharmacological and biomedical literature database renowned for its coverage of the drug-related literature. It is updated weekly and contains the most recent 8 weeks' worth of data, and on average contains approximately 80,000 records.

EMBASE AlertTM comprises bibliographic records that have not yet been indexed by the EMBASE editors. Most records consist of bibliographic citations containing abstracts and author-supplied keywords.

EMBASE Alert is not cumulative, but rather a "rolling" file; as a new update is added each week, the oldest week is deleted. Citations can be found with full indexing in EMBASETM (File 72) just a few weeks following their appearance in EMBASE Alert.

Citations from more than 5,000 journals from about 70 countries are included.



Tips [top]

USE FILE 172

to search for the very latest biomedical and pharmaceutical articles; use it together with EMBASE (Files 72 and 73) for both current and comprehensive information.

USE FREE TEXT SEARCHING

in the Basic Index since the records include no controlled subject indexing.

USE LIMITS

to restrict search results to English (/ENG) or to records containing abstracts (/ABS).



Subject Coverage [top]

  • Drug Research, Pharmacology, Pharmacoeconomics, Pharmaceutics, and Toxicology
  • Human Medicine (Clinical and Experimental)
  • Basic Biological Research
  • Health Policy and Management
  • Public, Occupational, and Environmental Health
  • Substance Dependence and Abuse
  • Psychiatry
  • Forensic Science


Print Counterparts [top]

  • None


Dialog File Data [top]

Dates Covered: Current 8 weeks
File Size: Approximately 170,000 records
Update Frequency: Daily


Document Types Indexed [top]

  • Journal Articles


Geographic Coverage [top]

  • International


Geographic Restrictions [top]

  • None


Special Features [top]


DialIndex/OneSearch Categories [top]

ACRONYM CATEGORY NAME
ALTMED Alternative Medicine
BIOCHEM Biochemistry
BIOSCI Biosciences
BIOTECH Biotechnology
HEALTH Health
MEDDEV Medical Devices
MEDENG Medical Engineering
MEDICINE Medicine
NUTRIT Nutrition
PHARM Pharmacology
PHARMR Pharmacology + RINGDOC-Files
SAFETY Safety
TOXICOL Toxicology


Contact [top]

Elsevier B.V.
P.O. Box 211
Amsterdam, 1000 AE
The Netherlands
Telephone: +31-20-4853-507
Fax: +31-20-4853-432
E-Mail: ebd-marketing@elsevier.com


Terms and Conditions [top]

For Dialog's Redistribution and Archive Policy, enter HELP ERA online. Note, however, that Embase Alert has a separate Archive policy and data may only be held in electronic form for a maximum period of 12 months from the date it is first downloaded and must then be deleted. Those customers that want to archive beyond 12 months should contact their Account Manager or nearest Customer Services desk to obtain an extended archiving license. The following terms and conditions also apply.

The database is owned and copyrighted by Elsevier B.V. NEITHER ELSEVIER NOR ANY OF ITS AFFILIATES OR LICENSORS SHALL BE LIABLE TO YOU OR ANYONE ELSE FOR ANY LOSS OR INJURY, CAUSED IN WHOLE OR PART BY ITS NEGLIGENCE OR CONTINGENCIES BEYOND ITS CONTROL IN PROCURING, COMPILING, INTERPRETING, REPORTING, OR DELIVERING INFORMATION THROUGH THE SITE. IN NO EVENT WILL ELSEVIER, ITS AFFILIATES OR LICENSORS BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE ON SUCH INFORMATION. ELSEVIER AND ITS AFFILIATES AND LICENSORS SHALL NOT BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DAMAGES (INCLUDING, WITHOUT LIMITATION, CONSEQUENTIAL, SPECIAL, INCIDENTAL, INDIRECT, OR SIMILAR DAMAGES) EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or advertised on our system.


Dialog Standard Terms & Conditions apply.


SAMPLE RECORD [top]

  AA=  0000153833     EMBASE No: 2008465216 
  /TI   The management of exfoliative glaucoma 
      ISSUE TITLE: Glaucoma: An Open Window to Neurodegeneration and 
    Neuroprotection 
  AU=    Ritch R. 
  CS=    New York Eye and Ear Infirmary, New York, NY 10003, United States 
      AUTHOR EMAIL: ritchmd@earthlink.net 
  CS=    CORRESP. AUTHOR/AFFIL: Ritch R.: New York Eye and Ear Infirmary, New 
    York, NY 10003, United States 
      CORRESP. AUTHOR EMAIL: ritchmd@earthlink.net 
  AU=    EDITOR(S): Osborne N.N.; Bagetta G. 
  CS=    University of Rome Tor Vergata, Dept. of Biopathol. and Diagnostic I, 
      Ophthalmological Unit, Rome, Italy; University of Oxford, Nuffield 
      Laboratory of Ophthalmology, Oxford, United Kingdom; University of 
      Calabria, Department of Pharmacobiology, Cosenza, Italy 
     
  JN=,CP=,PD=,PY=,SO=    Progress in Brain Research ( Prog. Brain Res. ) (Netherlands)  January 1, 
      2008, 173/- (211-224) 
  PU=    PUBLISHER: Elsevier 
  CD=,SN=,BN=    CODEN: PBRRA   ISSN: 0079-6123  ISBN: 9780444532565 
      PUBLISHER ITEM IDENTIFIER: S0079612308011151 
      DOI: 10.1016/S0079-6123(08)01115-1 
  DT=,RT=    DOCUMENT TYPE: Book Series; Review  RECORD TYPE: Abstract 
  LA=,SL=    LANGUAGE: English   SUMMARY LANGUAGE: English 
      NUMBER OF REFERENCES: 114 
  /AB    Exfoliation syndrome (XFS) is an age-related, generalized disorder of the 
    extracellular matrix characterized by the production and progressive 
    accumulation of a fibrillar extracellular material in many ocular tissues 
    and is the most common identifiable cause of open-angle glaucoma worldwide. 
    XFS plays an etiologic role in open-angle glaucoma, angle-closure glaucoma, 
    cataract, and retinal vein occlusion. It is accompanied by an increase in 
    serious complications at the time of cataract extraction, such as zonular 
    dialysis, capsular rupture, and vitreous loss. It is associated 
    systemically with an increasing number of vascular disorders, hearing loss, 
    and Alzheimer's disease. XFS appears to be a disease of elastic tissue 
    microfibrils. The characteristic fibrils, composed of microfibrillar 
    subunits surrounded by an amorphous matrix comprising various 
    glycoconjugates, contain predominantly epitopes of elastic fibers, such as 
    elastin, tropoelastin, amyloid P, vitronectin, and components of elastic 
    microfibrils, such as fibrillin-1, fibulin-2, vitronectin, 
    microfibril-associated glycoprotein (MAGP-1), and latent TGF-beta binding 
    proteins (LTBP-1 and LTBP-2), the proteoglycans syndecan and versican, the 
    extracellular chaperone clusterin, the cross-linking enzyme lysyl oxidase, 
    and other proteins. A recent milestone study showed that two common single 
    nucleotide polymorphisms in the coding region of the lysyl oxidase-like 1 
    (LOXL1) gene located on chromosome 15 were specifically associated with XFS 
    and XFG. LOXL1 is a member of the lysyl oxidase family of enzymes, which 
    are essential for the formation, stabilization, maintenance, and remodeling 
    of elastic fibers and prevent age-related loss of elasticity of tissues. 
    LOXL1 protein is a major component of exfoliation deposits and appears to 
    play a role in its accumulation and in concomitant elastotic processes in 
    intra- and extraocular tissues of XFS patients. This discovery should open 
    the way to new approaches and directions of therapy for this protein 
    disorder. (c) 2008 Elsevier B.V. All rights reserved. 
     
  /ID  AUTHOR KEYWORDS: conformational disorder; exfoliation syndrome; exfoliative 
    glaucoma; extracellular matrix; fibrillin; glaucoma; LOXL1 


BASIC INDEX [top]

SEARCH
SUFFIX		 DISPLAY
CODE		 FIELD NAME
 INDEXING
 SELECT EXAMPLES
None None All Basic Index Fields Word S PROTEIN(W)DISORDER
/AB AB Abstract1 Word S OCCULAR(W)TISSUES/AB
/ID ID Author-Supplied Keywords1,2,3 Word
& Phrase		 S FIBRILLIN/ID
S EXTRACELLULAR MATRIX/ID
/TI TI English Title, Original Non-English Title, or Issue Title Word S EXFOLIATIVE(W)GLAUCOMA/TI

1 Not present in every record.

2 Also /IF.

3 Also searchable as /KW.


ADDITIONAL INDEXES [top]

SEARCH
PREFIX		 DISPLAY
CODE		 FIELD NAME
 INDEXING
 SELECT EXAMPLES
AA= AA EMBASE ID Number Phrase S AA=2008465216
AU= AU Author Phrase S AU=RITCH R.
None AZ DIALOG Accession Number
BN= BN International Standard Book Number Phrase S BN=9780444532565
CD= CD CODEN Phrase S CD=PBRRA
CP= CP Country of Publication Word
& Phrase		 S CP=NETHERLANDS
S CP=HONG KONG
CS= CS Corporate Source Word
& Phrase		 S CS=(NEW(W)YORK(W)EYE)
S CS=NEW YORK EYE 'AND' EAR?
DT= DT Document Type Phrase S DT=BOOK SERIES
None II Publisher Item Identifier (PII) or Digital Object Identifier
JN= JN Journal Name Phrase S JN=PROGRESS IN BRAIN RESEARCH
LA= LA Language Phrase S LA=ENGLISH
NO= NO Article Number Phrase S NO=C02108SS
PD= PD Publication Date Phrase S PD=20080101
PU= PU Publisher Word S PU=ELSEVIER
PY= PY Publication Year Phrase S PY=2008
None RF Number of References
RT= RT Record Type Phrase S RT=ABSTRACT
SL= SL Summary Language Phrase S SL=ENGLISH
SN= SN International Standard Serial Number (ISSN) Phrase S SN=0079-6123
S SN=00796123
SO= SO Source Information Word S SO=(PROG(W)BRAIN(W)RES? AND 173)
UD= None Update Phrase S UD=9999


LIMIT [top]

SUFFIX FIELD NAME EXAMPLES
/ABS Abstract Present S PHYSICAL ACTIVITY/ID,ABS
/ENG English Language S ALZHEIMER(W)S/TI,ENG
/NOABS No Abstract Present S S1/NOABS
/NOENG Non-English Language S S2/NONENG
/YYYY Publication Year S NUTRITION(F)CHILD?/2008


SORT [top]

SORTABLE FIELDS EXAMPLES
AU, CS, JN, PY, TI SORT S1/ALL/AU


RANK [top]

RANK FIELDS EXAMPLES
All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. Other RANK codes include: BN RANK ID
RANK AU S4


USER-DEFINED FORMAT OPTIONS [top]

Display codes listed in the Search Options tables can be used to customize output. TYPE S3/TI,ID/1-5


PREDEFINED FORMAT OPTIONS [top]

NO.
 DIALOGWEB
FORMAT		 RECORD CONTENT
1 -- DIALOG Accession Number
2 -- Full Record except Abstract
3 Medium Bibliographic Citation
4 -- Full Record with Tagged Fields1
5 -- Full Record1
6 Free Title
7 Long Bibliographic Citation and Abstract1
8 Short Title
9 Full Full Record1
K -- KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats


DIRECT RECORD ACCESS [top]

FIELD NAME EXAMPLES
If the accession number of a specific record is known, it can be used to display the record directly. TYPE 169293/9
DISPLAY 168850/TI,AU
PRINT 171941/7


Rates [top]

Rates For File: EMBASE® Alert[172]
Cost per DialUnit:                $17.44
Cost per minute:                   $3.56
Rank Elements                      $0.00
ALERT (default)                    $9.81
ALERT (Monthly)                *  $64.64
ALERT (Biweekly/twice a month) *  $54.82
ALERT (Weekly)                    $44.70
ALERT (Daily)                      $9.81
ALERT (Calendar weekly)        *  $44.70
ALERT (Intraday)               *   $9.81
* = custom scheduled Alerts only
ALERT Number of included prints       20

Format    Types   Prints
     1    $0.00    $0.00
     2    $5.65    $5.65
     3    $5.65    $5.65
     4    $5.65    $5.65
     5    $5.65    $5.65
     6    $0.00    $0.00
     7    $5.65    $5.65
     8    $0.00    $0.00
     9    $5.65    $5.65
KWIC95    $0.57       NA
KWIC96    $0.57       NA

REDIST/COPY Multiplier Table:

      Range      Multiplier
        1-2       1.00
       3-25       1.50
     26-100       3.00
    101-200       4.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

ARCHIVE Multiplier Table:

      Range      Multiplier
       1-25       1.50
     26-200       3.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00
[top]


All contents Copyright © Dialog, LLC. All rights reserved.
If you have any questions about, problems with, or corrections for our Web site,
please contact Customer Service for assistance.